Post Pandemic Outcomes
When the pandemic hit and Covid-19 spread across the world, Signant Health made the decision to move its global workforce of 2,000 employees, based across the US, Europe and Asia, to a programme of remote working.
Just days before the remote working decision was made, Addin365 had launched Signant’s new Intranet, Navigator. Built using Addin Intranet, Navigator was engineered to minimise the set-up time and encourage quick adoption rates when compared to more traditional custom or intranet product routes.
Navigator served as the critical communications hub for all employees. The success of Navigator gave the Signant leadership teams confidence that they would be able to communicate essential business updates to their workers instantly with relevant and targeted content during such a vital period.
The Navigator platform proved crucial by not only connecting the Signant leadership to employees with two-way communications, but also allowed for clinical trial progress to be reported to the relevant internal teams, no matter their location or time zone. Signant Health undertook an immense scaling of operations across the business to support the clinical trials of newly developed vaccines and treatments for COVID19 for their customers, including Pfizer.
Navigator has allowed Signant Health to support the radically changing needs of the pharmaceutical companies at the forefront of developing Covid-19 vaccines and treatments with clinical trials and supplies.